Capturing Readmission Internationally to Prevent Readmission by Safer@Home Group (CURIOS@)
Capturing Readmission Internationally to Prevent Readmission by Safer@Home
Sponsor: Amsterdam UMC, location VUmc
Listed as NCT02621723, this observational or N/A phase trial focuses on Hospital Readmission and remains ongoing. Sponsored by Amsterdam UMC, location VUmc, it has been updated 8 times since 2016, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
May 2022 — Jul 2024 [monthly]
Unknown Status
-
Jan 2021 — May 2022 [monthly]
Unknown Status
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status
▶ Show 3 earlier versions
-
Apr 2018 — Jun 2018 [monthly]
Unknown Status
Phase: NA → None
-
Feb 2018 — Apr 2018 [monthly]
Unknown Status NA
Status: Not Yet Recruiting → Unknown Status
-
Jan 2017 — Feb 2018 [monthly]
Not Yet Recruiting NA
First recorded
Jan 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Amsterdam UMC, location VUmc
For direct contact, visit the study record on ClinicalTrials.gov .